This content is restricted.
Brief
"On June 27, 2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Clinical study on the Touchcare insulin pump in a hybrid closed loop promoted by the company Medtrum: suspension of the inclusion of new patients. This decision was made due to non-compliance with regulations related to the reporting of adverse events, including severe cases of hyperglycemia and hypoglycemia that were not reported by the manufacturer."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested